{
    "code": "02010815",
    "許可證字號": "衛署藥輸字第010815號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/09\/21",
    "註銷理由": "屆期未申請展延",
    "有效日期": "93\/01\/19",
    "發證日期": "72\/01\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201081505",
    "中文品名": "歐利停錠２５０公絲",
    "英文品名": "ORIMETENE TABLETS 250MG",
    "適應症": "停經後期或卵巢切除後之婦女移轉性乳癌（特別是對婦女激素過敏性腫瘤）下列原因引起的ＣＵＳＨＩＮＧ？Ｓ　ＳＹＮＤＲＯＭＥ腎上腺皮質腫瘤（腺癌或癌）腎上腺皮質增殖、從垂體以外產生ＡＣＴＨ（異位ＡＣＴＨ症狀），移轉性前列腺癌的舒解療法",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "AMINOGLUTETHIMIDE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1422701100  臺灣諾華股份有限公司",
    "申請商地址": "台北巿大安區仁愛路２段９９號１１Ｆ",
    "主製造廠": {
        "製造廠名稱": "F430088000  NOVARTIS PHARMA STEIN AG",
        "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
        "製造廠公司地址": "CH-4002,BASEL,SWITZERLAND",
        "製造廠國別": "SWITZERLAND",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6808002100",
            "成分名稱": "AMINOGLUTETHIMIDE",
            "含量描述": "250.0",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "CG",
        "標記二": "G,G"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "圖片",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02010815&Seq=419&Type=10"
        }
    ]
}